|
| Exchange Disseminated Time | Lincoln Pharmaceuticals Ltd has informed BSE regarding a Press Release dated February 07, 2011 titled "Lincoln Pharmaceuticals Ltd. introduces India's first Long-Acting Paracetamol 'Pa-12' for Long term relief from Fever and Pain"
Press Release :
"Lincoln Pharmaceuticals Limited (LPL), Ahmedabad based world class pharmaceutical company recognized for manufacturing top class quality Health Care Products, announced the launch of a novel drug delivery system in Paracetamol, Pa-12 - India's first Long-Acting Paracetamol (Long-acting pain medications stay in your system for an extended period of time) for long term relief from fever and pain at a press conference in the city today. Paracetamol is the time tested molecule that controls fever and pain by working on the hypothalamus gland of the human brain. In comparison to conventional oral paracetamol tablets, Indian' clinical trials have proven Pa12 to be more effective with longer acting action and fewer side effects. Pa-12 contains 1000mg paracetamol, programmed for "Hon-Stop 12 hours fever control with 1 tab only". In a day a patient will need only two tablets of Pa-12 instead of 3 to 4 tablets of conventional oral paracetamol tablets.
Under the conventional treatment for fever and pain, patients are given 500 mg or 650 mg tablets of paracetamol which may exhibit some limitation related to repeat dosages in 24 hours. Moreover the side effect profile is higher with higher frequency of dosage regimens. To find a solution to this problem, LPL carried out two years of indigenous research and developed a novel drug delivery system with a new, formulation for a Long Acting Paracetamol, Pa-12. Clinical trials of more than 500 patients at leading Indian hospitals have proven and established the efficacy and tolerability of this product in comparison to other paracetamol brands available in the market.
Speaking at the press conference on the launch of the new drug delivery system, PA-12 Mr. Mahendra G Patel, MD, Lincoln Pharmaceutical Ltd. said "We are very excited by this latest innovation from our R&D facility. Our endeavor to constantly develop new formulations with the goal of providing improved healthcare products, for better treatment has again paid off. The launch of Pa-12 with its advanced formulation will provide relief to people suffering from pain and high temperature more effectively. With just a single tablet the patient's pain and fever will be acted upon for 12 hours at a stretch with lower, side effects. The initial test phase in the market has been very encouraging and we are sure that the formulation will be well accepted by the medical foraternity".
Speaking on this occasion Mr. Rajani G Patel, Joint Managing Director, Lincoln Pharmaceutical Ltd. said, "Pain and fever is a problem associated with several illnesses. With our company motto being "Healthcare for All" it was only natural for us to try and find a better remedy for the suffering patients Now with the Pa-12 providing longer lasting treatment with a single dosage it is certainly going to be a boon for many. We at Lincoln Pharmaceutical Ltd are very happy to be a part of the solution" He further added, "We have applied for a patent for this novel drug delivery system of Paracetamol. While we are initially launching Pa-12 in the domestic market, we have plans to market this product internationally as well. This new launch will strengthen our position in the pharmaceutical industry and will pave the path for stupendous growth." |
|
|